Detalhe da pesquisa
1.
Puerarin ameliorated pressure overload-induced cardiac hypertrophy in ovariectomized rats through activation of the PPARα/PGC-1 pathway.
Acta Pharmacol Sin
; 42(1): 55-67, 2021 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-32504066
2.
Contributions of Nrf2 to Puerarin Prevention of Cardiac Hypertrophy and its Metabolic Enzymes Expression in Rats.
J Pharmacol Exp Ther
; 366(3): 458-469, 2018 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-29945930
3.
Azilsartan ameliorates ventricular hypertrophy in rats suffering from pressure overload-induced cardiac hypertrophy by activating the Keap1-Nrf2 signalling pathway.
J Pharm Pharmacol
; 73(12): 1715-1725, 2021 Dec 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-34343333
4.
Nrf2 Is a Key Regulator on Puerarin Preventing Cardiac Fibrosis and Upregulating Metabolic Enzymes UGT1A1 in Rats.
Front Pharmacol
; 9: 540, 2018.
Artigo
em Inglês
| MEDLINE | ID: mdl-29928229
5.
Puerarin-7-O-glucuronide, a water-soluble puerarin metabolite, prevents angiotensin II-induced cardiomyocyte hypertrophy by reducing oxidative stress.
Naunyn Schmiedebergs Arch Pharmacol
; 390(5): 535-545, 2017 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-28210753